SnagRx and Embody

Two storefronts operated by one company. Both name the same four filling pharmacies, the same prescriber network, and the same Wilmington address.

Passes 7 of 8 criteria. Recorded against Standard v1.1, August 2026.

Operating entity Modern Metabolic Medicine, Inc. One entity operates 2 storefronts, recorded here as one entry: snagrx.com, joinem.co.

Dispositions at a glance

Code	Criterion	Disposition
S1	Prescriber requirement	PASS
S2	Prescription gating	PASS
S3	Pharmacy identification	PASS
S4	Compounding disclosure	PASS
S5	Analytical documentation	FAIL
S6	Business address	PASS
S7	Price disclosure	PASS
S8	Enforcement status	PASS

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSBoth storefronts state that medical treatment is provided by OpenLoop Health, a network of United States licensed doctors.Source: snagrx.com, joinem.co · read August 2026.

S2PASSThe order path was walked on both storefronts and stopped at the first intake question, which asks height and weight.Source: snagrx.com/intake, joinem.co/pages/begin · read August 2026.

S3PASSFour pharmacies named with street addresses and phone numbers: Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine, Triad Rx.Source: snagrx.com, joinem.co · read August 2026.

S4PASSCompounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality, printed under the price cards.Source: joinem.co · read August 2026.

S5FAILUpdated reports on medication testing are described as received from pharmacies; no lot document is reachable on either storefront.Source: snagrx.com, joinem.co · read August 2026.

S6PASSModern Metabolic Medicine, Inc. at 1811 Silverside Road, Suite 260, Wilmington, New Castle County, Delaware 19180.Source: snagrx.com/contact · read August 2026.

S7PASSSemaglutide at 69 dollars per month and tirzepatide at 119 dollars per month, printed under a stated holiday discount.Source: snagrx.com · read August 2026.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index · read August 2026.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded GLP-1/GIP.

Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.